A novel enzymatic reaction involved in the metabolism of aliphatic epoxides by Xanthobacter strain Py2 is described. Cell extracts catalyzed the CO 2 -dependent carboxylation of propylene oxide (epoxypropane) to form acetoacetate and -hydroxybutyrate. The time courses of acetoacetate and -hydroxybutyrate formation indicate that acetoacetate is the primary product of propylene oxide carboxylation and that -hydroxybutyrate is a secondary product formed by the reduction of acetoacetate. Analogous C 5 carboxylation products were identified with 1,2-epoxybutane as the substrate. In the absence of CO 2 , propylene oxide and 1,2-epoxybutane were isomerized to form acetone and methyl ethyl ketone, respectively, as dead-end products. The carboxylation of short-chain epoxides to -keto acids is proposed to serve as the physiological reaction for the metabolism of aliphatic epoxides in Xanthobacter strain Py2.Xanthobacter strain Py2 is one of several bacteria capable of aerobic growth with aliphatic alkenes as carbon and energy sources (4). The pathway of alkene metabolism involves an initial monooxygenase-catalyzed reaction producing epoxide intermediates (12), as shown for the substrate propylene and the product propylene oxide (epoxypropane) in the following equation:Aliphatic epoxides such as propylene oxide have toxic, mutagenic, and potential carcinogenic properties (2, 13), and their metabolism in bacteria and mammalian systems has been the focus of considerable research in recent years. The best-characterized epoxide-degrading enzymes are the detoxifying epoxide hydrolases of mammalian cells, which hydrate epoxides to dihydrodiols (11). The hydrolysis of epoxides to diols has also been described as a bacterial mechanism for the utilization of epoxides as carbon and energy sources (1, 6). Another mechanism has been described for styrene-degrading bacteria, which metabolize the styrene epoxidation product, styrene oxide, via an isomerization reaction which yields phenylacetaldehyde as an intermediate product (5,8).The isomerization of short-chain epoxides to ketones (Fig. 1A) has been observed in whole-cell suspensions (10) and cell extracts of Xanthobacter strain Py2 (14). However, these ketones are not further metabolized, suggesting that they are not the physiological products of epoxide conversions. Recently, we demonstrated that the isomerization of epoxides to ketones by whole-cell suspensions of Xanthobacter Py2 occurred only when CO 2 was excluded from the assay mixture (9). This observation was extended to demonstrate that the metabolism of propylene oxide proceeds by a CO 2 -dependent reaction which was proposed to produce acetoacetate, or a derivative thereof (9). This proposed carboxylation, shown in Fig. 1B, represents a new and novel strategy for epoxide conversion distinct from hydrolytic and isomerization mechanisms such as those described above.To date, no direct evidence for epoxide carboxylation has been provided through in vitro studies. In this study, the in vitro carboxylation of short-chain...